Team:Goettingen/HumanPractice/v1

From 2013.igem.org

(Difference between revisions)
(Navigation)
(Navigation)
Line 21: Line 21:
**[[Team:Goettingen/HumanPractice/v3|Street Interview]]
**[[Team:Goettingen/HumanPractice/v3|Street Interview]]
*<html><a href="https://docs.google.com/forms/d/1ZRpyowfl9TZgov878VbCtl26n6DnpvHY9Tx9FGTAPCI/viewform" target="_blank">Online Questionnaire</a></html>
*<html><a href="https://docs.google.com/forms/d/1ZRpyowfl9TZgov878VbCtl26n6DnpvHY9Tx9FGTAPCI/viewform" target="_blank">Online Questionnaire</a></html>
-
*[[Team:Goettingen/HumanPractice/Survey/Results|Sutvey Results]]
+
*[[Team:Goettingen/HumanPractice/Survey/Results|Survey Results]]
=== ===
=== ===

Revision as of 11:38, 1 October 2013





The beast and its Achilles heel:

 A novel target to fight multi-resistant pathogenic bacteria


Interview with Dr.Perl

Dr.Thorsten Perl is a Senior resident at the Hospital of University. As a medical doctor working in intensive care unit (ICU), he has handled infection caused by multi-resistant bacteria. In this interview, he has given us a fresh view from the battlefront against multi-resistance. This video is in German

Antibiotic Resistances: A Look into the Intensive Care Unit

scripts for testing!
Sam:hello, welcome!
Nina:hello,welcome!

 

Previous Next